ITEOS THERAPEUTICS INC (ITOS)

US46565G1040 - Common Stock

7.66  -0.14 (-1.79%)

Premarket: 7.76 +0.1 (+1.31%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
344.8M267.6M
-22.39%		12.595M
-95.29%		46.75M
271.18%		6.828M
-85.39%		15.138M
121.70%		117.94M
679.10%		91.648M
-22.29%		166.74M
81.94%		256.94M
54.10%		525.94M
104.69%		541.4M
2.94%
EBITDA
YoY % growth
245.5M
649.22%		127.1M
-48.23%		-150.203M
-218.18%		-163.2M
-8.65%		-178.5M
-9.38%		-202.98M
-13.71%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
244.9M
641.81%		126.3M
-48.43%		-151.101M
-219.64%		-167.772M
-11.03%		-219.46M
-30.81%		-245.455M
-11.84%		-182.308M
25.73%		-172.676M
5.28%		-85.285M
50.61%		5.486M
106.43%		180.55M
3,191.10%		180.91M
0.20%
Operating Margin
71.03%47.20%-1,199.69%-358.87%-3,214.12%-1,621.45%-154.58%-188.41%-51.15%2.14%34.33%33.42%
EPS
YoY % growth
5.61
334.29%		N/A
-50.69%		-3.15
-213.87%		-3.41
-8.35%		-4.31
-26.30%		-4.29
0.38%		-3.28
23.59%		-2.45
25.29%		-1.06
56.73%		0.04
104.16%		2.72
6,066.28%		2.71
-0.37%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth		-1.26
-48.00%		-1.32
-23.81%		-1.38
-667.74%		-1.34
-28.07%		-1.23
2.49%		-1.32
0.29%		-1.34
3.24%		-1.35
-0.43%		-1.36
-11.00%		-2.03
-53.90%		-1.76
-31.50%		-1.57
-16.47%
Revenue
Q2Q % growth
-100.00%		807.33KN/AN/AN/AN/AN/AN/A4.709M
EBITDA
Q2Q % growth		-51M
-29.94%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-54.704M
-36.26%		-66.137M
-40.03%		-67.269M
-374.86%		-67.33M
-37.98%		-68.289M
-24.83%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -1.05
-16.67%		-0.91-0.14-15.79%
Q2 2024
Q2Q % growth		 -0.18
81.25%		-1.060.8882.99%
Q1 2024
Q2Q % growth		 -1.07
-143.18%		-1.280.2116.49%
Q4 2023
Q2Q % growth		 -0.85
-349.75%		-1.050.2019.34%
Q3 2023
Q2Q % growth		 -0.90
-3,100.00%		-1.230.3326.68%
Q2 2023
Q2Q % growth		 -0.96
-740.00%		-1.050.098.62%
Q1 2023
Q2Q % growth		 -0.44
-124.18%		-1.010.5756.62%
Q4 2022
Q2Q % growth
-93.04%		0.34%
Q3 2022
Q2Q % growth		 0.03
-98.39%		0.10-0.07-69.83%
Q2 2022
Q2Q % growth		 0.15
120.00%		1.23-1.08-87.77%
Q1 2022
Q2Q % growth		 1.82
566.67%		0.811.01124.44%
Q4 2021
Q2Q % growth		 4.89
1,237.21%		1.303.59275.13%
Q3 2021
Q2Q % growth		 1.86
487.50%		5.05-3.19-63.18%
Q2 2021
Q2Q % growth		 -0.75
97.46%		-0.42-0.33-77.61%
Q1 2021
Q2Q % growth		 -0.39 -0.490.1020.01%
Q4 2020
Q2Q % growth		 -0.43 -0.430.000.22%
Q3 2020
Q2Q % growth		 -0.48 -0.37-0.11-29.28%
Q2 2020
Q2Q % growth		 -29.49 -0.48-29.01-6,084.33%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 17M-17M-100.00%
Q2 2024
Q2Q % growth		 35M 1.02M33.98M3,331.37%
Q1 2024
Q2Q % growth
-100.00%		%
Q4 2023
Q2Q % growth
-100.00%		%
Q3 2023
Q2Q % growth
-100.00%		%
Q2 2023
Q2Q % growth
-100.00%		%
Q1 2023
Q2Q % growth		 12.595M
-91.74%		8.199M4.396M53.62%
Q4 2022
Q2Q % growth		 53.9M
-77.59%		41.979M11.921M28.40%
Q3 2022
Q2Q % growth		 19.5M
-81.30%		42.889M-23.389M-54.53%
Q2 2022
Q2Q % growth		 41.7M 87.269M-45.569M-52.22%
Q1 2022
Q2Q % growth		 152.5M 64.566M87.934M136.19%
Q4 2021
Q2Q % growth		 240.5M 87.168M153.332M175.90%
Q3 2021
Q2Q % growth		 104.3M 164.35M-60.05M-36.54%
Q2 2021
Q2Q % growth		 3.984M-3.984M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -10.86% 12.37% 15.88%
RevenueN/A -100% 0% 0%